Bisdemethoxycurcumin suppresses liver fibrosis-associated hepatocellular carcinoma via inhibiting CXCL12-induced macrophage polarization
摘要： Chronic, unresolved inflammation correlates with persistent hepatic injury and fibrosis, ultimately progressing to hepatocellular carcinoma(HCC). Bisdemethoxycurcumin(BDMC)demonstrates thera... ...
（共16頁）
開通會員，享受整站包年服務(wù)
說明： 本文檔由創(chuàng)作者上傳發(fā)布，版權(quán)歸屬創(chuàng)作者。若內(nèi)容存在侵權(quán)，請點擊申訴舉報
APP